As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.

A panel of experts went over new regulatory requirements for contamination control and gave guidance on implementing a contamination control strategy in cell and gene therapy facilities at INTERPHEX ...

(MENAFN- GlobeNewsWire - Nasdaq) This course explores Annex 1's requirements, focusing on aseptic operations, CCS, and quality assurance. Attendees gain insights into regulatory expectations, ...

This whitepaper by West Pharmaceutical Services explores how pharmaceutical manufacturers and suppliers can confidently navigate the revised EU GMP Annex 1 guidelines for sterile drug production. It ...